In general, LSINCT5 plays a carcinogenic role in osteosarcoma cells and may be a predictor of the clinical outcomes of osteosarcoma patients, and a promising candidate for osteosarcoma prognosis and treatment. This evidence concerns the gene LSINCT5 and osteosarcoma.